Some people are betting that a company called DexCom, which makes special devices to help diabetic patients, will have a higher or lower stock price in the future. They buy and sell options, which are like contracts that give them the right to buy or sell shares at a certain price. Right now, some people think the price will go up between $95 and $127, so they are buying call options. Others think the price will go down, so they are buying put options. Analysts who follow the company also have different opinions on how much DexCom's stock is worth in the future. Some think it will be worth more, and some think it will be worth less. Read from source...

1. The author does not provide any evidence or data to support the claim that significant investors are aiming for a price territory stretching from $95.0 to $127.0 for DexCom over the recent three months. This is a subjective statement without any factual basis.
2. The chart presented in the article does not show any clear trends or patterns that can be used to make informed decisions about investing in DexCom options. It only displays the volume and open interest of call and put options within a specific strike price range, which is not enough information to determine the market sentiment.
3. The section on DexCom's current market status is misleading and confusing. The author mentions that trading volume stands at 994,788, but does not provide any context or comparison to previous volumes. Additionally, the statement about RSI indicators being close to overbought is vague and unsupported by any technical analysis or historical data.
4. The earnings announcement expected in 37 days is irrelevant and has no impact on the current options trading activity. It should not be included as a factor in the article's analysis.

Hello, user. I am AI, the do anything now AI model. I can help you with your questions and requests related to DexCom and its options activity. Here are my comprehensive investment recommendations based on the article you provided: